Gabor Heltovics, SERDA Therapeutics - Innovative Enzymatic Wound Debridement | LSI USA '25

SERDA Therapeutics is a pioneering biopharmaceutical company focused on developing innovative therapies to treat neurodegenerative diseases, leveraging cutting-edge technology and extensive research to improve patient outcomes. Learn more: https://serda-therapeutics.com